Trial Details

TERMINATED
Basic Information
Clinical ID c3923
Identifier NCT01316939
Trial Title GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions DRUG: GSK1605786A|DRUG: Placebo|DRUG: GSK1605786A
Participant Information
Sponsor GlaxoSmithKline
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2011-05-09
Primary Completion Date 2013-10-23
Completion Date 2013-10-23